Jan 3
|
Alcohol brands startled by Surgeon General's cancer risk advisory
|
Jan 3
|
Bud and Molson Stock Fall as Surgeon General Warns of Beer and Wine’s Cancer Link
|
Jan 3
|
Beer and alcohol stocks face bigger challenges as US surgeon general links drinking to cancer risk
|
Jan 3
|
Update: Alcohol Beverage Stocks Fall After US Surgeon General Calls for Cancer Warnings on Alcoholic Drinks
|
Jan 3
|
Alcohol stocks slip after US Surgeon General's call for warning label
|
Jan 3
|
Anheuser-Busch, Booze Stocks Hit By Surgeon General's Warning On Alcohol Link To Cancer
|
Jan 3
|
Social stigma still overshadows 0.0 drinks for Gen Z, even as Diageo, Heineken, and AB InBev bet big on alcohol-free options
|
Jan 2
|
AB InBev Trades Below 200 & 50-Day SMAs: How to Play the Stock?
|
Dec 31
|
Is Anheuser-Busch InBev (BUD) the Best Brewery Stock to Buy According to Hedge Funds?
|
Dec 31
|
Turkish Brewer Anadolu Efes Extends Slump After Russia JV Decree
|
Dec 31
|
Putin Hands Local Company Control of AB InBev’s Russian Unit
|
Oct 3
|
Port strike could threaten liquor industry during holidays
|
Sep 30
|
Anheuser-Busch invests $16M in facility to boost drinks ‘beyond beer’
|
Sep 26
|
Anheuser-Busch Invests $16M in Los Angeles Brewery
|
Sep 26
|
Anheuser-Busch invests $16m in Los Angeles facility
|
Sep 26
|
The Weekly Sip: Anheuser-Busch unveils Michelob Ultra Zero | Boston Beer takes Truly to brunch
|
Sep 25
|
Anheuser-Busch Invests $16M to Bring Increased Capabilities and Capacity to Los Angeles Brewery
|
Sep 6
|
Zacks Industry Outlook Highlights Anheuser-Busch InBev, Constellation Brands, Molson Coors and The Duckhorn Portfolio
|
Sep 5
|
4 Alcohol Industry Stocks to Navigate Industry Challenges
|
Sep 4
|
More Ways to Michelada: THC-Infused Michelada goes Mainstream...
|